Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Garver, David L.
and
Hutchinson, Leslie J.
1988.
Psychosis, lithium-induced antipsychotic response, and seasonality.
Psychiatry Research,
Vol. 26,
Issue. 3,
p.
279.
Sautter, Frederic J.
McDermott, Barbara E.
and
Garver, David L.
1990.
A family study of lithium-responsive psychosis.
Journal of Affective Disorders,
Vol. 20,
Issue. 1,
p.
63.
Kaplan, Marcia J.
Lazoff, Marjorie
Kelly, Kathleen
Lukin, Robert
and
Garver, David L.
1990.
Enlargement of cerebral third ventricle in psychotic patients with delayed response to neuroleptics.
Biological Psychiatry,
Vol. 27,
Issue. 2,
p.
205.
Zemian, Frank P.
Thienhaus, Ole J.
and
Garver, David L.
1990.
Length of psychiatric hospitalization and prediction of antipsychotic response.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 14,
Issue. 1,
p.
IN1.
Van Kammen, Daniel P.
1991.
The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis.
Psychological Medicine,
Vol. 21,
Issue. 4,
p.
881.
Beinfeld, Margery C.
and
Garver, David L.
1991.
Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: Relationship to symptoms and drug response.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 15,
Issue. 5,
p.
601.
Chouinard, Guy
1991.
Severe cases of neuroleptic-induced supersensitivity psychosis.
Schizophrenia Research,
Vol. 5,
Issue. 1,
p.
21.
Sautter, Frederic
McDermott, Barbara
and
Garver, David
1993.
Familial differences between rapid neuroleptic response psychosis and delayed neuroleptic response psychosis.
Biological Psychiatry,
Vol. 33,
Issue. 1,
p.
15.
Müller-Spahn, F.
Hock, C.
and
Kurtz, G.
1994.
Prediction of Neuroleptic Treatment Outcome in Schizophrenia.
p.
111.
Buchsbaum, M. S.
and
Luu, C. T.
1994.
Prediction of Neuroleptic Treatment Outcome in Schizophrenia.
p.
123.
Van Kammen, D. P.
1995.
Psychotic Continuum.
p.
107.
Meltzer, H. Y.
1995.
Psychotic Continuum.
p.
31.
Grof, P.
1997.
Die Lithiumtherapie.
p.
251.
Kingsbury, Steven J.
and
Garver, David L.
1998.
Lithium and psychosis revisited.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 22,
Issue. 2,
p.
249.
Tollefson, Gary D.
Sanger, Todd M.
Beasley, Charles M.
and
Tran, Pierre V.
1998.
A Double-Blind, Controlled Comparison of the Novel Antipsychotic Olanzapine versus Haloperidol or Placebo on Anxious and Depressive Symptoms Accompanying Schizophrenia.
Biological Psychiatry,
Vol. 43,
Issue. 11,
p.
803.
Wyatt, Richard Jed
Henter, Ioline D
and
Bartko, John J
1999.
The long-term effects of placebo in patients with chronic schizophrenia.
Biological Psychiatry,
Vol. 46,
Issue. 8,
p.
1092.
Joober, Ridha
Rouleau, Guy A
Lal, Samarthji
Dixon, Michael
O'Driscoll, Gillian
Palmour, Roberta
Annable, Lawrence
Bloom, David
Lalonde, Pierre
Labelle, Alain
and
Benkelfat, Chawki
2002.
Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers.
Schizophrenia Research,
Vol. 53,
Issue. 3,
p.
229.
Donnelly, Lorna
Waraich, Paul S
Adams, Clive E
Hamill, Karen M
Marti, Joan
Roqué i Figuls, Marta
Rathbone, John
and
Waraich, Paul S
2002.
Cochrane Database of Systematic Reviews.
Garver, David L
Tamas, Rebecca L
and
Holcomb, Jennifer A
2003.
Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype.
Neuropsychopharmacology,
Vol. 28,
Issue. 8,
p.
1515.
Leucht, S
McGrath, J
Kissling, W
and
Leucht, Stefan
2003.
Cochrane Database of Systematic Reviews.